Bone mineral content and bone mineral metabolism: changes after growth hormone treatment in juvenile chronic arthritis.

OBJECTIVE: To determine whether growth hormone (rhGH) affects bone mineral metabolism and bone mineral content (BMC, g/cm) in a therapeutic trial of recombinant growth hormone in growth retarded children with juvenile chronic arthritis (JCA) treated with steroid. METHODS: BMC was measured in 20 chil...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: Rooney, M, Davies, U, Reeve, J, Preece, M, Ansell, B, Woo, P
Format: Journal article
Sprache:English
Veröffentlicht: 2000
_version_ 1826306084462133248
author Rooney, M
Davies, U
Reeve, J
Preece, M
Ansell, B
Woo, P
author_facet Rooney, M
Davies, U
Reeve, J
Preece, M
Ansell, B
Woo, P
author_sort Rooney, M
collection OXFORD
description OBJECTIVE: To determine whether growth hormone (rhGH) affects bone mineral metabolism and bone mineral content (BMC, g/cm) in a therapeutic trial of recombinant growth hormone in growth retarded children with juvenile chronic arthritis (JCA) treated with steroid. METHODS: BMC was measured in 20 children (of whom 17 were treated with corticosteroid) before and after one year of rhGH. Children were randomized to receive either low dose (12 IU/m2/week) or high dose (24 IU/m2/week) for one year. Three monthly assessments were made of disease activity and anthropomorphic measurements. Blood and urine samples were also obtained to measure indicators of disease activity, bone remodeling, and vitamin D and parathyroid hormone (PTH) status. RESULTS: BMC increased during the treatment period and correlated with increasing height. Osteocalcin levels, normally indicators of bone formation, increased after rhGH treatment and correlated significantly with height velocity, particularly for the high dose treatment group. In contrast, osteocalcin levels were negatively correlated with C-reactive protein levels, both before and during treatment. Height velocity, vitamin D, PTH, and osteocalcin levels were significantly lower than age matched controls before treatment. CONCLUSION: Steroid treated children with both JCA and severe growth retardation have reduced vitamin D, PTH, and osteocalcin levels. After treatment with rhGH, height velocity increased, as did BMC. Growth hormone might be a useful adjunct in the treatment of severe growth retardation and osteoporosis in children with JCA. The longterm benefits of rhGH in the treatment of osteoporosis remain unclear.
first_indexed 2024-03-07T06:42:34Z
format Journal article
id oxford-uuid:f9cb62b9-bfcd-47e3-af7e-6725cd5ed01c
institution University of Oxford
language English
last_indexed 2024-03-07T06:42:34Z
publishDate 2000
record_format dspace
spelling oxford-uuid:f9cb62b9-bfcd-47e3-af7e-6725cd5ed01c2022-03-27T13:00:39ZBone mineral content and bone mineral metabolism: changes after growth hormone treatment in juvenile chronic arthritis.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:f9cb62b9-bfcd-47e3-af7e-6725cd5ed01cEnglishSymplectic Elements at Oxford2000Rooney, MDavies, UReeve, JPreece, MAnsell, BWoo, POBJECTIVE: To determine whether growth hormone (rhGH) affects bone mineral metabolism and bone mineral content (BMC, g/cm) in a therapeutic trial of recombinant growth hormone in growth retarded children with juvenile chronic arthritis (JCA) treated with steroid. METHODS: BMC was measured in 20 children (of whom 17 were treated with corticosteroid) before and after one year of rhGH. Children were randomized to receive either low dose (12 IU/m2/week) or high dose (24 IU/m2/week) for one year. Three monthly assessments were made of disease activity and anthropomorphic measurements. Blood and urine samples were also obtained to measure indicators of disease activity, bone remodeling, and vitamin D and parathyroid hormone (PTH) status. RESULTS: BMC increased during the treatment period and correlated with increasing height. Osteocalcin levels, normally indicators of bone formation, increased after rhGH treatment and correlated significantly with height velocity, particularly for the high dose treatment group. In contrast, osteocalcin levels were negatively correlated with C-reactive protein levels, both before and during treatment. Height velocity, vitamin D, PTH, and osteocalcin levels were significantly lower than age matched controls before treatment. CONCLUSION: Steroid treated children with both JCA and severe growth retardation have reduced vitamin D, PTH, and osteocalcin levels. After treatment with rhGH, height velocity increased, as did BMC. Growth hormone might be a useful adjunct in the treatment of severe growth retardation and osteoporosis in children with JCA. The longterm benefits of rhGH in the treatment of osteoporosis remain unclear.
spellingShingle Rooney, M
Davies, U
Reeve, J
Preece, M
Ansell, B
Woo, P
Bone mineral content and bone mineral metabolism: changes after growth hormone treatment in juvenile chronic arthritis.
title Bone mineral content and bone mineral metabolism: changes after growth hormone treatment in juvenile chronic arthritis.
title_full Bone mineral content and bone mineral metabolism: changes after growth hormone treatment in juvenile chronic arthritis.
title_fullStr Bone mineral content and bone mineral metabolism: changes after growth hormone treatment in juvenile chronic arthritis.
title_full_unstemmed Bone mineral content and bone mineral metabolism: changes after growth hormone treatment in juvenile chronic arthritis.
title_short Bone mineral content and bone mineral metabolism: changes after growth hormone treatment in juvenile chronic arthritis.
title_sort bone mineral content and bone mineral metabolism changes after growth hormone treatment in juvenile chronic arthritis
work_keys_str_mv AT rooneym bonemineralcontentandbonemineralmetabolismchangesaftergrowthhormonetreatmentinjuvenilechronicarthritis
AT daviesu bonemineralcontentandbonemineralmetabolismchangesaftergrowthhormonetreatmentinjuvenilechronicarthritis
AT reevej bonemineralcontentandbonemineralmetabolismchangesaftergrowthhormonetreatmentinjuvenilechronicarthritis
AT preecem bonemineralcontentandbonemineralmetabolismchangesaftergrowthhormonetreatmentinjuvenilechronicarthritis
AT ansellb bonemineralcontentandbonemineralmetabolismchangesaftergrowthhormonetreatmentinjuvenilechronicarthritis
AT woop bonemineralcontentandbonemineralmetabolismchangesaftergrowthhormonetreatmentinjuvenilechronicarthritis